Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Avidity Partners Management LP
Form 13F · Q2 2026

Avidity Partners Management LP

CIK 1791827Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$624M
Reported book value
45
Positions
12
Quarters on record
Top 50
Positions

Avidity Partners Management LP — holdings

Top 45 positions of 45, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1DNTH Dianthus Therapeutics Inc2.1M+0.0%$205M32.8%
2CGON Cg Oncology Inc1.4M+8.5%$99M15.9%
3ORKA Oruka Therapeutics Inc760,424+0.0%$72M11.6%
4JBIO Jade Biosciences Inc1.7M+21.4%$38M6.1%
5ELVN Enliven Therapeutics Inc550,000+37.5%$28M4.5%
6CATX Perspective Therapeutics Inc6.3M+4.1%$21M3.4%
7AKTS Aktis Oncology Inc484,200+3.3%$16M2.5%
8PVLA Palvella Therapeutics Inc Ne70,000+0.0%$11M1.7%
9MOBI Mobia Med Inc798,282—$11M1.7%
10RGEN Repligen Corp77,800+0.0%$11M1.7%
11IMUX Immunic Inc669,941—$10M1.6%
12SENS Senseonics Hldgs Inc1.6M—$9M1.5%
13KPTIQ Karyopharm Therapeutics Inc924,487+99.4%$9M1.4%
14TEVA PHARMACEUTICAL INDS LTD Teva Pharmaceutical Inds Ltd200,000−55.6%$7M1.1%
15DXCM Dexcom Inc100,000+11.1%$7M1.1%
16TEM Tempus Ai Inc105,000+320.0%$6M1.0%
17MDT Medtronic Plc70,000−30.0%$5M0.9%
18VIR Vir Biotechnology Inc519,300−45.3%$5M0.8%
19GPCR Structure Therapeutics Inc98,000+226.7%$5M0.8%
20EHC Encompass Health Corp42,000+0.0%$4M0.7%
21TENX Tenax Therapeutics Inc265,934+23.2%$4M0.6%
22NVCT Nuvectis Pharma Inc200,000—$4M0.6%
23PODD Insulet Corp24,000—$4M0.6%
24BSX Boston Scientific Corp80,000+33.3%$3M0.5%
25MSLE Satellos Bioscience Inc387,769+0.0%$3M0.5%
26ALMR Alamar Biosciences Inc110,000—$3M0.5%
27CNTX Context Therapeutics Inc5.0M+0.0%$3M0.4%
28GILD Gilead Sciences Inc20,000+0.0%$3M0.4%
29CHARLES RIV LABS INTL INC Charles Riv Labs Intl Inc10,000—$2M0.4%
30PHAT Phathom Pharmaceuticals Inc200,000−19.8%$2M0.3%
31AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc60,000—$2M0.3%
32KLRA Kailera Therapeutics Inc80,000—$2M0.3%
33GMAB Genmab A/S50,000+0.0%$1M0.2%
34NTLA Intellia Therapeutics Inc75,000+0.0%$1M0.2%
35CRVS Corvus Pharmaceuticals Inc80,000−30.4%$1M0.2%
36ODD Oddity Tech Ltd70,000+0.0%$1M0.2%
37SCYX Scynexis Inc260,206—$1M0.2%
38EVMN Evommune Inc75,000—$996,7500.2%
39ABT Abbott Laboratories10,000—$907,4000.1%
40BBIO Bridgebio Pharma Inc10,000—$744,8000.1%
41PTON Peloton Interactive Inc100,000−50.0%$591,0000.1%
42LEGN Legend Biotech Corp15,000—$433,2000.1%
43BBOT Bridgebio Oncology Therapeut43,853+0.0%$334,1600.1%
44SVRA Savara Inc50,000—$308,0000.0%
45TRVI Trevi Therapeutics Inc6,660+0.0%$124,2090.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.